Ì«Ñô¼¯ÍŹÙÍø

English Ì«Ñô¼¯ÍŹÙÍø¼¯ÍÅÆóÒµÓÊÏä

ÔÙÉúÒ½ÁÆÊÖÒÕÅäºÏ΢Á£Æ¤ÅàÖ²ÐÞ¸´Æ¤·ôÂýÐÔÀ£Ññ´´ÃæµÄÁÙ´²ÆÊÎö

2013Äê-11ÔÂ-25ÈÕ ÈªÔ´£ºÌ«Ñô¼¯ÍŹÙÍø¹ú¼Ê¼¯ÍÅ

ÄÏ·½Ò½¿Æ´óѧÖÐҽҩѧԺ£¬ºÎÈÊÁÁ  Ñî¡¡Áø;  ÖÐɽÊÐ»ÆÆÔÈËÃñÒ½Ôº£¬ÓàÖ¾ºÍ£¬ÁõÓ¢Ï飬Àî·ï´º
  ¹ãÖÝÖÐÒ½Ò©´óѧÁ¥ÊôµÚ¶þÒ½Ôº£¬ÀîºìÒã

¡¾ÕªÒª¡¿¡¡Ä¿µÄ£ºÌ½ÌÖÔÙÉúÒ½ÁÆÊÖÒÕÅäºÏ×ÔÌå΢Á£Æ¤ÅàÖ²±íƤ»¯ÔÚÆ¤·ôÂýÐÔÀ£Ññ´´ÃæÐÞ¸´ÖÎÁÆÖеÄÓ¦Óá£ÒªÁ죺ÏÈʹÓÃÆ¤·ôÍâ¿ÆÊÖÒÕɨ³ý´´Ã滵ËÀ×éÖ¯ºó£¬Ê¹ÓÃʪÈóÉÕÉ˸à×÷ÓýÈâÑ¿£¬È»ºó°´À£Ññ´´Ãæ£ºÈ¡Æ¤Ãæ»ý=20¡«30¡Ã1µÄ±ÈÀýÈ¡ÈͺñƤ¼ô³É΢Á£Æ¤Á£ºóݪֲÓÚÈâÑ¿ÖУ¬ÔÙÓÃʪÈóÉÕÉ˸àÅàֲ΢Á£Æ¤Ö±ÖÁ±íƤ»¯ÐÞ¸´´´Ã档Ч¹û£º2005Äê9ÔÂ~2007Äê9ÔÂÎÒÃÇÓÃ΢Á£Æ¤ÝªÖ²ÊõÖÎÁÆ31ÀýƤ·ôÂýÐÔÀ£Ññ»¼Õß»ñµÃÖª×ãЧ¹û¡£½áÂÛ£ºÎ¢Á£Æ¤ÝªÖ²ÊõÍŽáʪÈóÉÕÉ˸àÖÎÁÆÆ¤·ôÂýÐÔÀ£Ññ£¬ ÊÖÊõ²Ù×÷¼òÆÓ£¬Êõºó¹©Æ¤ÇøÓúºÏºÃ£¬À£ÑñÇøÐÞ¸´ºóƤ·ôÈáÈí¡¢ñ£ºÛÉÙ¡¢¹¦Ð§Ó°ÏìС£»ÓÉÓÚÊÖÊõÈ¡Æ¤Ãæ»ýԶԶСÓÚ´´Ã棬΢Á£Æ¤Ö±½ÓݪֲÓÚ´´ÃæÈâÑ¿ÄÚ£¬Êõºó¶Ô´´ÃæÊàŦ»î¶¯ÒªÇóÏà¶ÔµÍ£¬ÒÔÊÇ»¼ÕßÒÀ´ÓÐԺᣱ¾·¨ÈõµãÊDz¿·Ö²¡ÀýݪֲµÄ΢Á£Æ¤³É»îÂʽϵÍ£¬Ðë¶à´Îݪֲ£¬ÐÞ¸´Ê±¼ä¿ÉÄܽϳ¤¡£
¡¾Òªº¦´Ê¡¿¡¡ÔÙÉúÒ½ÁÆÊÖÒÕ;Ƥ·ôÂýÐÔÀ£Ññ£»×ÔÌå΢Á£±íÆ¤ÒÆÖ²

Clinical Report of Repair of Chronic Skin Ulcers with Autografting Microparticle Skin£®HE Ren-liang1, YU Zhi-he2, LIU Ying-xiang2, et al£®1£®School of Traditional Medicine, Southern Medical University, Guangzhou City, Guangdong Province, 516000, China; 2£®Dept£®of Dermatology, the People's Hospital, Huangpu District, Zhongshan City, Guangdong Province, 528429, China£®
¡¾Abstract¡¿¡¡Objective: To explore the epidemic repair of chronic skin ulcers treating with autografting microparticle skin£®Method: After necrotic tissue removed at the wound with surgery method and granulation tissue cultured with MEBO, microparticle skin tablet prapared with split-thickness skin according to the proportion of 20~30:1 (Ulcer area : skin area) and then the skin tablets were cultivated at granulation with MEBO till epidemic repair completed£®Result: All 31 cases of chronic ulcer patients collected from Sep£® 2005 to Sep£®2007 were treated with microparticle skin tablets culture and  satisfactory effect was obtained£®Conclusion: Treating chronic ulcers with microparticle skin tablets autografting cultured by MEBO has advantages£¬such as simple operation, good repair effect for donate site wound; and soft skin, less scar formation and better joint function obtained at healed ulcer wound site£®Because the area of donor site was far less than that of ulcer wound and microparticle skin tablets were planted into granulation directly, little requirement for the joint function was required after surgery, so it is more acceptable by the patient£®But, there are some disadvantages including lower survival rate of microparticle skingrafting£®For some patients, multiple grafting and longer repair time are required sometime£®
¡¾Key words¡¿¡¡Chronic skin  ulcer; Auto-microparticle skingrafting; Plantation
ÓÉÓÚȱ·¦ÓÕµ¼±íƤÉú³¤·¢ÓýµÄ΢ÇéÐΣ¬ÌåÍâÁ¢Ìå×÷ÓýµÄ±íƤϸ°ûûÓе䷶µÄ±íƤ½á¹¹[1]£¬Òò´Ë²»¿ÉÓÐÓõØÐÞ¸´Æ¤·ô´´Ã档ʪÈóÉÕÉ˸ࣨ¼ò³ÆMEBO£©×÷Ϊ´´ÃæÐÞ¸´µÄÒ»ÖÖ¾ßÓÐ×ÔÖ÷֪ʶ²úȨµÄÖÐÒ©ÖÆ¼Á£¬²»µ«ÔÚԭλ¾ßÓиÉϸ°ûÅàÖ²×÷Óã¬ÔÚÌåÍâÒ²¾ßÓиÉϸ°ûÅàÖ²×÷ÓÃ[2]¡£ÎªÁËÊÓ²ì×ÔÌå΢Á£Æ¤ÝªÖ²ÊõÍŽáMEBOÖÎÁÆÆ¤·ôÂýÐÔÀ£ÑñµÄÁÆÐ§£¬ÎÒÃÇʹÓÃ×ÔÌå΢Á£Æ¤ÝªÖ²ÊõÍŽáMEBO¶Ô31ÀýȱËðÔÚ5cm2ÒÔÉÏµÄÆ¤·ô´´Ãæ¾ÙÐÐÐÞ¸´£¬²¢¾ÙÐÐÈ«³ÌµÄÁÙ´²ÊӲ졣ÏÖ±¨¸æÈçÏ£º
1£®ÁÙ´²×ÊÁÏ
1£®1£®Ò»Ñùƽ³£×ÊÁÏ£ºËùÓв¡Àý¾ùΪÎÒ¿Æ×¡Ôº²¡Àý£¬ÆäÖÐÄÐ18Àý£¬Å®13Àý£»×î´óÄêËê78Ë꣬×îСÄêËê19Ë꣬ƽ¾ùÄêËê52.7Ëꣻ²¡³Ì×5Ä꣬×î¶Ì4¸öÔ£¬Æ½¾ù²¡³Ì9.6¸öÔ£»ÌÇÄò²¡ÐÔÆ¤·ôÀ£Ññ7Àý£¬´´ÉËÐÔÀ£Ññ5Àý£¬Ñ¹Á¦ÐÔÀ£Ññ6Àý£¬ °©ÐÔÀ£Ññ3Àý£¬ÉÕÉËÊ£Óà´´ÃæÀ£Ññ5Àý£¬·ÅÉäÐÔÀ£Ññ2Àý£¬ÊÖÊõÇпÚÓúºÏ²»Á¼ÐÔÀ£Ññ3Àý£»À£ÑñÃæ»ý×îС2.3cm×2.8cm£¬×î´ó15cm×12cm£¬Æ½¾ù4cm×2.3cm¡£
1£®2£®Õï¶Ï±ê×¼£º²ÎÕÕÈì´¯ Wagner·Ö¼¶1~2¼¶¾ÙÐÐÀ£Ññ·Ö¼¶¡£
1£®3£®ÈëÑ¡²¡Àý£ºÐķθÎÉö¹¦Ð§ÓÅÒ죬Ƥ·ôÀ£Ññ²¡³Ì1¸öÔÂÒÔÉÏ¡¢Ãæ»ý´óÓÚ5cm2Õß¡£
1£®4£®É¨³ý²¡Àý£º£¨1£©ÕýÔÚ½ÓÊÜÌÇÆ¤Öʼ¤ËØ¡¢ÃâÒßÒÖÖÆ¼Á¼°Ö×Áö»¯ÁÆÕß¡££¨2£©ÕýÔÚ½ÓÊÜ»òÒÑÍù1 ¸öÔÂÄÚ½ÓÊܹýÉú³¤Òò×ÓÖÎÁÆÕß¡££¨3£©²î±ðÒâ½ÓÊÜ×ÔÌå΢Á£Æ¤ÝªÖ²ÊÖÊõÕß¡££¨4£©À£Ññ´´ÃæÃæ»ý<5cm2Õß¡£
1£®5£®ÌÞ³ý²¡Àý£ºÒòÖÖÖÖÔµ¹ÊÔ­ÓÉÖÐ;Í˳ö»òδÍê³ÉÖÎÁƵϼÕß¡£
1£®6£®´´ÃæÆÀ¹À±ê×¼£º
1£®6£®1£®´´Ãæ·Ö¼¶¼°¼Ç·Ö£º1¼¶£ºÕæÆ¤È«²ãÊÜË𣬴©ÈëÆ¤ÏÂ×éÖ¯£¬µ«ÉÐδ´©Í¸½îĤ¼°¼¡Èâ²ã£»2¼¶£ºÈ«Æ¤²ãË𺦣¬´©Í¸½îĤ£¬Éî´ï¼¡Èâ²ã£» 3¼¶£ºÈ«Æ¤²ãË𺦣¬´©Í¸½îĤ¼°¼¡Èâ²ã£¬Éî´ï¹Ç÷À£¬Ö¹Ç÷ÀÍâ¶¡£
1£®6£®2£®ÉË¿ÚÆÀ¹À£º²ÎÕÕ¡¶ÊÊÓÃÉË¿ÚÕչ˻¤Ê¿Ñ§¡·ÉË¿ÚÆÀ¹À±íÖÆ¶©ÈçÏ£º
£¨1£©À£ÑñÍâòɫÔó£º
4·Ö£ººìÈó£»
3·Ö£ºµ­ºìÉ«£»
2·Ö£º°µºìÉ«£»
1·Ö£º×ϰµ»ò²Ò°×É«¡£
£¨2£©ÉË¿ÚÉøÒºÁ¿£º
4·Ö£ººÜÉÙÁ¿£ºÉË¿ÚÍâòʪÈ󣬵«ÎÞ·¨ÕÉÁ¿³öÉøÒºÁ¿£¬»òûÓÐÉøÒº£»
3·Ö£ºÉÙÁ¿£ºÉË¿ÚÉøÍ¸ÒºÉÙ£¬Õ´ÊªÄÚ²ã·óÁÏ≤25£¥£»
2·Ö£ºÖÐÁ¿£ºÉøÍ¸ÒºÕ´ÊªÄÚ²ã·óÁÏ26%¡«75£¥£»
1·Ö£º´ó×Ú£ºÉøÍ¸ÒºÕ´ÊªÄÚ²ã·óÁÏ76%¡«100£¥¡£
£¨3£©ÐÂÉúÈâÑ¿×éÖ¯
    4·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ≥76%£»
    3·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ51%¡«75%£»
    2·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ26%¡«50%£»
¡¡¡¡1·Ö£ºÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ≤25%¡£
£¨4£©ÐÂÉúÉÏÆ¤×éÖ¯
4·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý≥76%£»
3·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý51%¡«75%£»
2·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý26%¡«50%£»
1·Ö£ºÐÂÉúÉÏÆ¤×éÖ¯ËùÁýÕÖ´´ÃæÃæ»ý≤25%¡£
1£®7£®ÖÎÁÆÒªÁ죺ËùÓÐÄÉÈëÕß½øÈëÑо¿Ê±¾ùÓèÒÔ¼û¸æ²¢Ç©ÊðÖªÇéÔÞ³ÉÊé¡£
1£®7£®1£®È«ÉíÖÎÁÆ£ºÁ½×鲡È˾ùʹÓ㺣¨1£©Õë¶ÔÔ­·¢²¡µÄÖÎÁưüÀ¨½µµÍѪÌÇ¡¢ÔöÇ¿ÓªÑøÖ§³Ö¡¢¸ÄÉÆÎ¢Ñ­»·µÈ£»£¨2£©Æ¾Ö¤´´ÃæÏ¸¾ú¼°Õæ¾ú×÷Óý¼°Ò©ÃôЧ¹ûÑ¡ÔñÏìÓ¦µÄ¿¹¾úÖÎÁÆ¡£
1£®7£®2£®Î¢Á£Æ¤ÝªÖ²Êõ£º£¨1£©´´ÃæÔÚɨ³ý½¹ð衢ŧðèÒÔ¼°»µËÀ×éÖ¯ºó£¬ÓÃMEBOÒ©É´ÁýÕÖ´´Ã棬¼õѹ°üÔú£¬ÖðÈÕ1´Î£¬×÷ÓýÐÂÏʵÄÈâÑ¿£¬»»Ò©Ê±¼ÈÒª×öµ½Î¢´´ÕûÀí»µËÀ×éÖ¯£¬ÓÖҪʹ´´ÃæÉÙÊܴ̼¤£¬ÉÙ³öѪ¡££¨2£©Î¢Á£Æ¤ÖÖÆ¤Ê±»ú£ºÉË¿ÚÉøÍ¸ÒºÉÙ£¬Õ´ÊªÄÚ²ã·óÁÏ≤25£¥£¬ÐÂÏÊÈâÑ¿×éÖ¯ÔÚ´´ÃæÂþÑÜ51%¡«75%ÒÔÉÏ£¬´´ÃæÆÀ·Ö8·ÖÒÔÉÏ¡££¨3£©Î¢Á£Æ¤ÖÆ×÷£ºÍ¨Àýѡȡ¹©Æ¤Çø£¬Ïû¶¾Âé×íºó£¬°´È¡Æ¤Ãæ»ý£º´´ÃæÃæ»ý=1£º20¡«30µÄ±ÈÀýÈ¡ÈͺñƤƬ£¬ÔÚÎÞ¾úÐÄÀíÑÎË®Öмô³É0.1cm~0.2cm¾ÞϸµÄ΢Á£Æ¤¡££¨4£©Î¢Á£Æ¤ÝªÖ²£ºÏÈͨÀýÏû¶¾´´Ã棬ÓÃÑÛ¿ÆÎÞ³ÝÄ÷½«Î¢Á£Æ¤ÝªÖ²ÓÚ´´ÃæÈâÑ¿ÖУ¬¾àÀëÔ¼0.3cm~0.5cm£¬Éî¶ÈÔ¼0.2cm~0.3cm£¬ÎÞ¾úÉ´²¼Õ¥È¡Ö¹Ñª£¬È»ºóÁýÕÖÒ»²ãMEBOÒ©É´£¬ÎÞ¾úÉ´²¼°üÔú£¬ÌìÌì»»Ò©1´Î¡£´ýƤµºÀ©´óÏ໥ÈںϺóÔÙ¾Ö²¿·À°Ì´¦Öóͷ£¡£
1£®7£®3£®ÊÓ²ìʱ¼ä£ºÊõºó28Ìì¡£
1£®8£®ÊÓ²ìÖ¸±ê£º
1£®8£®1£®´´ÃæÃæ»ý£ºÓÃ͸Ã÷·½¸ñÖ½£¬ÔÚ»¼ÕßÈëԺʱÕÉÁ¿´´ÃæµÄÃæ»ýΪ³õÊ¼Ãæ»ý£¬ÁƳ̿¢ÊÂʱÕÉÁ¿¸÷ʱÏàµãµÄÐÞ¸´Ãæ»ý¡£ÅÌË㹫ʽ£º´´ÃæÓúºÏÃæ»ý°Ù·Ö±È£½£¨ÓúºÏÃæ»ý£¯³õÊ¼Ãæ»ý£©×100£¥¡£½ÓÄÉAdobe ImageReady 7.0ºÍOsirisÈí¼þÅÌËã´´ÃæÃæ»ý¡£

 

suncitygroupÌ«Ñô¼¯ÍÅ(Öйú)-¹Ù·½ÍøÕ¾

1£®8£®2£®´´ÃæÇéÐΣºÔÚÖÎÁÆÇ°ºóƾ֤´´ÃæÆÀ¼Û±ê×¼¼Æ·Ö£¬ ²¢ÉãÓ°Áô´æÕÕÆ¬¾ÙÐÐǰºó±ÈÕÕ¡£
1£®9£®ÖÎÁÆÐ§¹û£º
1£®9£®1£®ÆÀ¼Û±ê×¼£º°´´´ÃæÆÀ¹À±ê×¼¼Æ·Ö×ܵ÷־ÙÐÐÆÀ¼Û£¬ÖÎÓú£º16·Ö£»ÓÐÓÃ12·Ö¡«15·Ö£»ÎÞЧ<12·Ö¡£
1£®9£®2£®ÁÙ´²ÊÓ²ìЧ¹û£ºÖÎÁÆ4Öܺó×ÛºÏÆÀ·Ö16·ÖµÄ25Àý£¬15·ÖµÄ2Àý£¬12·Ö4Àý¡£ÖÎÁÆ8ÖܺóÖ»ÓÐ2Àý×Ü»ý·ÖΪ12·Ö£»ÖÎÁÆ12ÖܺóËùÓв¡Àý»ý·Ö¾ù´ï15·ÖÒÔÉÏ¡£
2£®½áÂÛ
4ÖÜÊÓ²ìÆÚÖÎÓú25Àý£¬ÁÆÐ§ÓÅÒì6Àý¡£Î¢Á£Æ¤ÝªÖ²ÊõÍÅ½áÆ¤·ôԭλÔÙÍâÐÐÒÕÖÎÁÆÆ¤·ôÂýÐÔÀ£Ññ£¬ ÊÖÊõ²Ù×÷¼òÆÓ£¬Êõºó¹©Æ¤ÇøÓúºÏºÃ£¬À£ÑñÇøÐÞ¸´ºóñ£ºÛÉÙÇÒÈáÈí£¬¹¦Ð§Ó°ÏìС£»ÓÉÓÚÊÖÊõÈ¡Æ¤Ãæ»ýԶԶСÓÚ´´Ã棬΢Á£Æ¤Ö±½ÓݪֲÓÚ´´ÃæÈâÑ¿ÄÚ£¬Êõºó¶ÔÏÞÖÆÊàŦ»î¶¯ÒªÇóÏà¶ÔµÍ£¬ÒÔÊÇ»¼ÕßÒÀ´ÓÐԺᣵ«²¿·Ö²¡ÀýݪֲµÄ΢Á£Æ¤³É»îÂʽϵÍ£¬Ðè¶à´Îݪֲ£¬ÐÞ¸´Ê±¼ä½Ï³¤¡£
3£®ÌÖÂÛ
Ƥ·ô´´ÃæÐÞ¸´Ò»Ö±ÊÇҽѧ½çºã¾Ã¹Ø×¢µÄ¿ÎÌâ[3~5]¡£ÏÖÔÚº£ÄÚÍâѧÕß¶ÔÆ¤·ôÂýÐÔÀ£ÑñµÄÖÎÁƾÙÐÐÁËÆÕ±éÑо¿£¬´ó¶¼ÒÔΪÊÖÊõÊÇ¿ØÖƺ;ÀÕý²¡Òò»ù´¡ÉϵÄÒ»ÖÖÐÐÖ®ÓÐÓõÄÖÎÁÆÊֶΣ¬µ«ÓÉÓÚÂýÐÔÀ£Ññ»¼Õß´ó¶àͬʱºÏ²¢È«ÉíÐÔ¼²²¡£¬ÈçÌÇÄò²¡£¬ÖзçºóµÄÖ«Ìå̱»¾£¬¼¹×µ´´ÉËËùÖµĽØÌ±£¬ÑÏÖØÈ«ÉíÓªÑø²»Á¼µÈ£¬Ê¹´óÃæ»ýƤ·ôÒÆÖ²»òƤ°ê×ªÒÆµÈÊÖÊõ·½·¨Êܵ½ºÜ´óÏÞÖÆ¡£·ÇÊÖÊõÖÎÁÆÒªÁì°üÀ¨£ºÖÐÒ½ÖÎÁÆ¡¢ÎïÀíÖÎÁÆ¡¢Ï¸°ûÒò×ÓÖÎÁÆ¡¢Æ¤·ô×éÖ¯¹¤³ÌʹÓᢹÇËè¼ä³äÖʸÉϸ°ûÖÎÁƵÈ£¬µ«¸÷×÷Õß±¨µÀµÄÁÆÐ§·×Æç¡£ÊªÈóÉÕÉ˸à¾ßÓÐìÉú¼¡¡¢»îѪ»¯ðöµÄ¹¦Ð§£¬ÔÚΪ´´ÃæÌṩÐÄÀíʪÈóÇéÐεÄͬʱ£¬ÄÜʹ»µËÀ×éÖ¯ºÍ´úл²úÆ·ÎÞËðÉ˵ÄÓɱíÈëÀïµØÒº»¯¡¢ÇãÔþ£¬Ê£ÓàÆ¤·ô×éÖ¯Ïò¸Éϸ°ûÆ«Ïòת»¯£¬×îÖÕʵÏÖÆ¤·ôԭλÔÙÉúÓúºÏ[6]¡£ÍâÑóѧÕßҲ֤ʵMEBO¶ÔƤ·ôÀ£ÑñÓÐÓÅÒìµÄÁÆÐ§[7]¡£ÂýÐÔÌå±íÀ£ÑñµÄÌØµãÊÇ´´ÔµÏËά×éÖ¯Î§ÈÆ¡¢´´ÖÜÉÏÆ¤ÅÀÐÐÊÜÏÞ£»´´ÃæÈâÑ¿×éÖ¯Óë´´ÖÜÉÏÆ¤×éÖ¯¸ôÀ룻´´ÃæÈâÑ¿×éÖ¯ÀÏ»¯¡¢²Ò°×£¬ÎÞÆ¤·ô×é֯ʣÓà¡£Òò´ËÑî¹úÃ÷[2]¡¢Íõ¼Ì»¸[8]¡¢ºÎÈÊÁÁ£Û9£ÝµÈ½ÓÄÉMEBO×÷ÓýÐÂÏÊÈâÑ¿ÔÙ×÷΢Á£Æ¤ÝªÖ²ÖÎÁÆ¢ó¶ÈÉîÐÍÉÕÉË´´ÃæÈ¡µÃÁËÓÅÒìЧ¹û£¬ÎÒÃÇʹÓÃMEBOÒ©¸àÍŽá×ÔÌå΢Á£Æ¤ÝªÖ²ÖÎÁÆÂýÐÔÆ¤·ôÀ£ÑñÅú×¢£¬¸ÃÊÖÒÕ²Ù×÷¼òÆÓ£¬ÎÞÐèÌØÊâÊÖÊõ×°±¸ºÍÕòÍ´ÒªÇó£»¾­ÅàÖ²µÄÐÂÉúƤÈáÈí£¬ÊàŦ¹¦Ð§»Ö¸´ºÃ£¬»¼ÕßÄÍÊÜÐԺã¬ÖÎÁÆÐ§¹ûÏÔÖø£¬ÓÈÆäÊÊÓÃÓÚ²»¿É½ÓÊÜ´óƬֲƤµÄ»¼Õß¡£
²Î ¿¼ ÎÄ Ï×
[1]Lamme EN£¬Van Leeuwen RT£¬Brandsma K£¬et al£®Higher numbers of autologous fibroblasts in an artificial substitute improve tissue regeneration and modulate scar tissue formation[J] £®J Pathol£¬2000£¬190£º595~603£®
[2] Ñî¹úÃ÷£¬ÕÔ¿¡Ï飬ӺÕþ£®MEBTÅäºÏÈâÑ¿´´ÃæÎ¢Á£Æ¤ÝªÖ²ÖÎÁÆÉî¢ó¶ÈÉÕÉË[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬1998£¬34£¨1£©£º28~29£®
[3] Scott PG£¬Ghahary A£¬Tredget EE£®Molecular and cellular aspects of fibrosis following thermal injury[J] £®Hand Clin£®2000£¬16£º271~287£®
[4] ¸¶Ð¡±ø£¬ËïͬÖù£¬ÑîÒø»Ô£¬µÈ£®¼îÐÔ³ÉÏËάϸ°ûÉú³¤Òò×ÓºÍת»¯Éú³¤Òò×Ó-βÔÚÀ£ÑñÓëÔöÉúÐ԰̺Û×éÖ¯Öеıí´ï¼°Æä¶Ô´´ÉËÐÞ¸´µÄÓ°Ïì[J] £®ÖйúÐÞ¸´ÖØÐÞÍâ¿ÆÔÓÖ¾£¬2000£¬14£º271~274£®
[5] Ñî´ºÃ÷£®¼±Ö¢Íâ¿ÆÑ§[M] £®µÚÒ»°æ£¬±±¾©£ºÈËÃñ¾üÒ½³öÊéÉ磬2001£º162~164£®
[6] ÐìÈÙÏ飬ÐíÔö»£®ÉÕÉËʪÐÔÒ½ÁÆÊÖÒÕ¶Ô±íÆ¤ÔÙÉú¸Éϸ°û×÷ÓõÄÑо¿[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬2000£¬3£º41~42£®
[7] Atiyeh BS£¬ Ioannovich J£¬ Magliacani G£¬ Masellis M£¬ Costagliola M£¬ Dham R£®The efficacy of MEBO £¨moist exposed burn ointment£© in the management of cutaneous wounds and ulcers£º a pilot study[J] £®Letter-to-the-editor£¬ Ann Plast Surg 2002£¬48£º 226~227£®
[8] Íõ¼Ì»¸£¬ÕŲÊϼ£®MEBOÖÎÁÆÍç¹ÌÐÔÂýÐÔÀ£Ññ168Àý[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬1998£¬34£¨4£©£º36~37£®
[9] ºÎÈÊÁÁ£¬ÁõÓ¢Ï飬³ÂÓÀÁˆ£¬µÈ£®×ÔÌå΢Á£Æ¤ÝªÖ²ÉÏÆ¤»¯ÔÙÉúÐÞ¸´´óÃæ»ýÉî¶ÈÉÕÉË´´Ãæ×é֯ѧÊÓ²ì[J] £®ÖйúÉÕÉË´´ÑñÔÓÖ¾£¬2007£¬19£¨1£©£º7~10£®
¡¾×÷Õß¼ò½é¡¿
ºÎÈÊÁÁ£¨1968~£©£¬ÄУ¨ºº×壩£¬ºþÄϰ²ÈÊÈË£¬ÄÏ·½Ò½¿Æ´óѧÔÚ¶Áҽѧ˶ʿ£¬Ö÷Òª´ÓÊÂÆ¤·ô¿Æ¡¢Æ¤·ô´´ÃæÐÞ¸´¡¢Æ¤·ôÍâ¿ÆÁÙ´²ºÍ¿ÆÑУ¬¿ÆÖ÷ÈΣ¬¸±Ö÷ÈÎҽʦ£®
ÓàÖ¾ºÍ£¨1971~£©£¬ÄУ¨ºº×壩£¬¹ã¶«ÖÐɽÈË£¬½áÒµÓÚÖÐɽ´óѧ£¬Ö÷Òª´ÓÊÂÍâ¿ÆÁÙ´²ºÍ¿ÆÑÐÒÔ¼°Ò½Ôº¹ÜÀí£¬¸±Ôº³¤£¬¸±Ö÷ÈÎҽʦ£®
ÁõÓ¢Ï飨1953~£©£¬ÄУ¨ºº×壩£¬¹ã¶«ÖÐɽÈË£¬½áÒµÓÚÖÐɽҽѧԺ£¬Ö÷Òª´ÓÊÂÍâ¿ÆÁÙ´²ºÍ¿ÆÑм°Ò½Ôº¹ÜÀí£¬Ôº³¤£¬¸±Ö÷ÈÎҽʦ£®

ÍøÕ¾µØÍ¼